Performant Healthcare, Inc.
PHLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.75 | -3.15 | 0.75 | 0.54 |
| FCF Yield | -0.36% | -0.12% | -2.80% | -1.31% |
| EV / EBITDA | -105.70 | 288.58 | 751.87 | 24.37 |
| Quality | ||||
| ROIC | -10.36% | -6.73% | -6.59% | -1.24% |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | -0.62 | -0.51 | 0.44 | -0.09 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.05% | -2.94% | -11.20% | -6.14% |
| Free Cash Flow Growth | -193.99% | 95.62% | -158.48% | -114.69% |
| Safety | ||||
| Net Debt / EBITDA | 0.20 | -2.06 | -6.29 | 0.73 |
| Interest Coverage | -8.60 | -3.10 | -6.85 | -0.12 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 74.42 | 92.41 | 97.58 | 90.85 |